MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1165/rcmb.2008-0071oc

Медицинская библиотека · American journal of respiratory cell and molecular biology · 2008

Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.

Reppe Katrin, Tschernig Thomas, Lührmann Anke, van Laak Vincent, Grote Karsten, Zemlin Maren V, Gutbier Birgitt, Müller Holger C, Kursar Mischo, Schütte Hartwig, Rosseau Simone, Pabst Reinhard, Suttorp Norbert, Witzenrath Martin

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Community-acquired pneumonia (CAP) is associated with high morbidity and mortality, and Streptococcus pneumoniae is the most prevalent causal pathogen identified in CAP. Impaired pulmonary host defense increases susceptibility to pneumococcal pneumonia. S. pneumoniae may up-regulate Toll-like receptor (TLR)-2 expression and activate TLR-2, contributing to pneumococcus-induced immune responses. In the current study, the course of severe murine pneumococcal pneumonia after pulmonary TLR-2-mediated immunostimulation with synthetic macrophage-activating lipopeptide-2 (MALP-2) was examined. Intratracheal MALP-2 application evoked enhanced proinflammatory cytokine and chemokine release, resulting in recruitment of polymorphonuclear neutrophils (PMN), macrophages, and lymphocytes into the alveolar space in WT, but not in TLR-2-deficient mice. In murine lungs as well as in human alveolar epithelial cells (A549), MALP-2 increased TLR-2 expression at both mRNA and protein level. Blood leukocyte numbers and populations remained unchanged. MALP-2 application 24 hours before intranasal pneumococcal infection resulted in increased levels of CCL5 associated with augmented leukocyte recruitment, and decreased levels of anti-inflammatory IL-10 in bronchoalveolar lavage fluid. Clinically, MALP-2-treated as compared with untreated mice showed increased survival, reduced hypothermia, and increased body weight. MALP-2 also reduced bacteremia and improved bacterial clearance in lung parenchyma, as examined by immunohistochemistry. In conclusion, pulmonary immunostimulation with MALP-2 before infection with S. pneumoniae improved local host defense and increased survival in murine pneumococcal pneumonia.

Для цитирования: Reppe Katrin, Tschernig Thomas, Lührmann Anke, van Laak Vincent, Grote Karsten, Zemlin Maren V, Gutbier Birgitt, Müller Holger C, Kursar Mischo, Schütte Hartwig, Rosseau Simone, Pabst Reinhard, Suttorp Norbert, Witzenrath Martin. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.. American journal of respiratory cell and molecular biology. 2008. DOI: 10.1165/rcmb.2008-0071oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.